- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of influenza
- Meeting Date: September 2022
- Public Summary Document (PSD) September 2022 PBAC Meeting - (PDF 984KB)
- Public Summary Document (PSD) September 2022 PBAC Meeting - (Word 155KB)
Quadrivalent influenza vaccine (surface antigen, inactivated, cell-based) – September 2022
Quadrivalent influenza vaccine (surface antigen, inactivated, cell-based): Injection 15 microgram in 0.5 mL needle-free pre-filled syringe, Injection 15 microgram in 0.5 mL pre-filled syringe with attached needle; Flucelvax® Quad – September 2022
Last updated
23 December 2022
